Alterations in the Smad pathway in human cancers
Authors:
- 1 January 2012
- journal article
- research article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 17 (1) , 1281-1293
Abstract
Members of the TGF-beta superfamily exhibit various biological activities, and perturbations of their signaling are linked to certain clinical disorders including cancer. The role of TGF-beta signaling as a tumor suppressor pathway is best illustrated by the presence of inactivating mutations in genes encoding TGF-beta receptors and Smads in human carcinomas. This perspective is further supported by studies of tumor development in mouse models after modulation of receptors and Smads. TGF-beta also controls processes such as cell invasion, immune regulation, and microenvironment alterations that cancer cells may exploit to their advantage for their progression. Consequently, the output of a TGF-beta response is highly situation dependent, across different tissues, and also in cancer in general. Understanding the mechanisms of TGF-beta superfamily signaling is thus important for the development of new ways to treat various types of cancer. This review focuses on recent advances in understanding the Smad dependent TGF-beta pathway as it relates to human carcinogenesis.Keywords
This publication has 119 references indexed in Scilit:
- Facilitated Transport of a Dpp/Scw Heterodimer by Sog/Tsg Leads to Robust Patterning of the Drosophila Blastoderm EmbryoCell, 2005
- Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancerOncogene, 2003
- Features of a Smad3 MH1-DNA ComplexJournal of Biological Chemistry, 2003
- Reconstitution of Smad3 restores TGF-β response of tissue inhibitor of metalloprotease-1 upregulation in human choriocarcinoma cellsBiochemical and Biophysical Research Communications, 2003
- Crystal Structure of a Phosphorylated Smad2Molecular Cell, 2001
- Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7Genes, Chromosomes and Cancer, 2001
- Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomasOncogene, 2000
- Targeted Disruption in Murine Cells Reveals Variable Requirement for Smad4 in Transforming Growth Factor β-related SignalingJournal of Biological Chemistry, 2000
- The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancerOncogene, 1999
- Mechanism of activation of the TGF-β receptorNature, 1994